Healthcare surged in June. Not in May. Not in July. June. The month wedged between Memorial Day trades and whatever the f*ck everyone pretends to do before the Fourth of July.
Raymond James responded to this thirty-day price movement by adding two dividend payers to their top picks list. They looked at one month of data and decided the entire thesis changed. That's the analytical rigor we've come to expect from firms that charge 1.2% to lose to an index fund.
The sector had a hot month, so naturally the play is to tell clients about it after it already happened. Revolutionary timing. Someone should write a book about buying high and hoping higher shows up to the party.
These are dividend payers, which means they're for people who need their portfolio to send them fifteen dollars every quarter so they can feel like Warren Buffett. The psychological comfort of a 2.3% yield while the stock drops 18% annually. But hey, passive income.
June was hot. The analysts at Raymond James noticed. They added stocks to a list. This is what passes for actionable intelligence in 2026. Not a study of balance sheets. Not a ten-year thesis on demographic shifts or regulatory tailwinds. Just vibes from a single summer month.
Retail traders will read this headline and think they're early. They'll buy these two mystery stocks on Monday morning, right after Raymond James clients already bought them on Thursday afternoon when the list actually came out. Then they'll watch their position go red by Tuesday and blame the Fed.
The best part is we don't even know which two stocks they picked. Could be Pfizer and Johnson & Johnson. Could be two medical device companies no one's heard of. Doesn't matter. The headline said healthcare surged, so someone's definitely buying a leveraged ETF at open.
Raymond James called the move after it moved. That's not analysis. That's just reading a calendar with extra steps.
Photo by Tech Daily on Unsplash
Leave a Comment